Evidence map›Paper›PMID 41927962›Full record

ReviewPharmaceutical research2026

New Vistas for Withania somnifera in Signal Transduction of Inflammation and Aging.

Eshita Sharma, Dilip Mehta, Prem Muthuraj, Sangita Panda, Saiprasad Ajgaonkar, Dishant Maniar, Aswathi Biju, Sujit Nair

Abstract readReview
In one paragraph

Review in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eshita SharmaPhytoveda Pvt. Ltd, Mumbai, 400022, India.
Dilip MehtaPhytoveda Pvt. Ltd, Mumbai, 400022, India.
Prem MuthurajPhytoveda Pvt. Ltd, Mumbai, 400022, India.ORCID http://orcid.org/0009-0001-1690-9433
Sangita PandaPhytoveda Pvt. Ltd, Mumbai, 400022, India.
Saiprasad AjgaonkarDrexel University, Philadelphia, PA, 19104, USA.
Dishant ManiarPhytoveda Pvt. Ltd, Mumbai, 400022, India.
Aswathi BijuSaveetha Medical College and Hospital, SIMATS, Chennai, 602105, India.
Sujit NairPhytoveda Pvt. Ltd, Mumbai, 400022, India. sujit108@gmail.com.ORCID http://orcid.org/0000-0002-7322-7375

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging in humans is a multidimensional complexity featured by systematic chronic inflammation and further accompanied by organ dysfunction, gut dysbiosis, immune senescence, and age-related diseases. Chronic inflammation in cells relates to secretory factors like the senescence-associated secretory phenotype which induces senescence in normal cells. Simultaneously, immune senescence is promoted by chronic inflammation, resulting in an impaired immune system unable to clear out senescent cells and inflammatory factors. Long term accumulation of elevated inflammatory factors in cells causes organ damage and leads to other age-related disorders. Eliminating inflammation could be a viable anti-aging strategy since it has been identified as an endogenous component in aging. Lately, products of natural origin have been gaining attention in combating age-related diseases and chronic inflammation. Various in vitro, in vivo, and clinical studies have well documented the role of Withania somnifera (WS) in alleviating inflammation and aging in cells by mediating several cellular signaling pathways. This review discusses the features and mechanisms of inflammation and aging (inflammaging) and the modulation of key associated pathways by WS, examining its role as a promising candidate for future strategies against inflammaging.

Indexed as

AgingAnti-Inflammatory AgentsInflammationPlant ExtractsWithaniaAnimalsCellular SenescenceHumansSignal TransductionAnti-Inflammatory AgentsPlant Extractsage-related diseasesepigeneticsinflammagingsignal transductionWithania somnifera

Identifiers

PMID41927962
PMCPMC13179179

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.